The agreement with the near-patient molecular diagnostics company, genedrive plc (LSE: GDR), is for distribution in the US and throughout Europe.

The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA. It offers lyophilized reagents that enable product stability and allow for ambient shipping and storage. The easy to set up assay can streamline laboratory workflows, increase overall throughput, and decrease potential errors for assay set up. The Genedrive 96 SARS-CoV-2 kit has received the CE-IVD mark and is currently under FDA review for Emergency Use Authorization (EUA).

Even as vaccines are being administered there is still a critical need to continue COVID-19 testing,” said Greg Milosevich, President, Beckman Coulter Life Sciences. “This collaboration provides a turnkey solution for specialized laboratories looking to establish new or expanded test capacity with consumables and labor cost reduction. The ability to streamline the workflow by simultaneously preparing...

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?